group_name,subgroup_name,count,diagnosis,male_count,female_count,age_mean,age_range,age_minimum,age_maximum,age_median,imaging_sample,pmcid
patients,schizophrenia,28,schizophrenia,20.0,8.0,,21-54,21.0,54.0,,yes,8883821.0
patients,autism spectrum disorder,20,autism spectrum disorder,16.0,4.0,,19-43,19.0,43.0,,yes,8883821.0
healthy,neurotypical controls,30,,22.0,8.0,,19-54,19.0,54.0,,yes,8883821.0
patients,ASD,539,autism spectrum disorder,,,,,,,,yes,9407088.0
healthy,controls,573,,,,,,,,,yes,9407088.0
patients,AIS,26,arterial ischemic stroke,,,13.02,,,,,yes,8785614.0
patients,PVI,26,periventricular venous infarction,,,11.93,,,,,yes,8785614.0
healthy,controls,31,,,,13.25,,,,,yes,8785614.0
patients,predatory violent offenders,7,predatory violent offenders,7.0,0.0,,,,,,yes,9230060.0
patients,affective violent offenders,6,affective violent offenders,6.0,0.0,,,,,,yes,9230060.0
patients,non-violent offenders,7,non-violent offenders,7.0,0.0,,,,,,yes,9230060.0
healthy,healthy controls,20,,20.0,0.0,,,,,,yes,9230060.0
healthy,included,121,,72.0,62.0,5.34,5.08-5.22,5.08,5.22,,yes,9108497.0
healthy,excluded,25,,,,,,,,,no,9108497.0
healthy,young adults,216,,,,,,,,,yes,8828908.0
patients,children and adolescents,167,varying levels of ADHD symptoms,111.0,56.0,10.74,5-18,5.0,18.0,,yes,8782893.0
healthy,HCP dataset,89,,44.0,45.0,,22-35,22.0,35.0,,yes,8752963.0
healthy,TÃ¼bingen dataset,23,,,,,,,,,yes,8752963.0
patients,GNE myopathy patient,1,GNE myopathy with congenital thrombocytopenia,1.0,0.0,29.0,29-29,29.0,29.0,29.0,yes,8978988.0
patients,LMTLE,12,left mesial temporal lobe epilepsy with hippocampal sclerosis,,,,,,,,yes,8933759.0
patients,RMTLE,11,right mesial temporal lobe epilepsy with hippocampal sclerosis,,,,,,,,yes,8933759.0
healthy,HC,23,,,,,,,,,yes,8933759.0
healthy,noncarriers,38,cognitively intact,16.0,22.0,49.9,40-60,40.0,60.0,,yes,9205431.0
patients,APOE-4 carriers,38,cognitively intact with APOE-4 genotype,16.0,22.0,49.9,40-60,40.0,60.0,,yes,9205431.0
patients,PCH patients,6,Pontocerebellar hypoplasia (PCH),3.0,2.0,7.3,,,,,yes,9461104.0
healthy,all participants,1418,,546.0,872.0,22.39,18-35,18.0,35.0,,yes,9564100.0
healthy,discovery sample,945,,,,,,,,,yes,9564100.0
healthy,replication sample,473,,,,,,,,,yes,9564100.0
healthy,community-dwelling young men,23,healthy,23.0,0.0,29.9,,,,,yes,9548384.0
patients,TSC1 variants,27,Tuberous sclerosis complex with TSC1 gene variants,4.0,17.0,,,,,,yes,9308181.0
patients,TSC2 variants,134,Tuberous sclerosis complex with TSC2 gene variants,48.0,59.0,,,,,,yes,9308181.0
patients,internet addiction,24,internet addiction,14.0,10.0,20.58,null,,,,yes,8939409.0
healthy,healthy controls,23,,10.0,13.0,21.13,null,,,,yes,8939409.0
patients,DLB,16,dementia with Lewy bodies,,,,,,,,yes,3984441.0
healthy,controls,17,,,,,,,,,yes,3984441.0
patients,AN,31,anorexia nervosa,0.0,31.0,,,,,,yes,3913832.0
healthy,HC,31,,0.0,31.0,,,,,,yes,3913832.0
healthy,subjects,18,,,,,,,,,yes,4352055.0
patients,primary sample,20,unipolar major depression,,,,18-65,18.0,65.0,,yes,5416685.0
healthy,primary sample controls,19,,,,,18-65,18.0,65.0,,yes,5416685.0
patients,validation sample,19,major depression with comorbid anxiety disorders,,,,18-65,18.0,65.0,,yes,5416685.0
healthy,validation sample controls,19,,,,,18-65,18.0,65.0,,yes,5416685.0
healthy,all participants,17,,7.0,10.0,26.0,21-31,21.0,31.0,,yes,8837589.0
healthy,controls,56,,30.0,26.0,,,,,,yes,7118554.0
patients,MDD,43,Major Depressive Disorder,13.0,30.0,,,,,,yes,7118554.0
patients,ASD,28,autism spectrum disorder,20.0,8.0,14.58,null,,,,yes,8213933.0
healthy,TD,27,typically developing,18.0,9.0,14.49,null,,,,yes,8213933.0
healthy,controls,90,,,,,,,,,yes,7416060.0
patients,cannabis users,54,chronic cannabis use,,,,,,,,yes,7416060.0
healthy,controls,31,,,,,,,,,yes,8933317.0
patients,TLE with memory intact,35,temporal lobe epilepsy with hippocampal sclerosis,,,,,,,,yes,8933317.0
patients,TLE with memory deficit,31,temporal lobe epilepsy with hippocampal sclerosis,,,,,,,,yes,8933317.0
healthy,controls,160,,115.0,45.0,37.04,19-59,19.0,59.0,,yes,7721229.0
patients,schizophrenia,151,schizophrenia,115.0,36.0,38.77,18-62,18.0,62.0,,yes,7721229.0
healthy,controls,314,,249.0,65.0,17.04,6.47-56.20,6.47,56.2,,yes,7721229.0
patients,autism spectrum disorder,255,autism spectrum disorder,224.0,31.0,17.05,7.00-55.40,7.0,55.4,,yes,7721229.0
patients,lung cancer patients before chemotherapy,18,lung cancer,,,,48-70,48.0,70.0,,yes,7275001.0
patients,lung cancer patients after chemotherapy,18,lung cancer,,,,48-70,48.0,70.0,,yes,7275001.0
healthy,healthy controls,21,,,,,48-70,48.0,70.0,,yes,7275001.0
healthy,HCP subjects,820,,,,,,,,,yes,6492297.0
healthy,controls,23,,15.0,8.0,31.1,19-44,19.0,44.0,,yes,5761874.0
patients,temporal lobe epilepsy,25,temporal lobe epilepsy,13.0,12.0,33.6,20-45,20.0,45.0,,yes,5761874.0
healthy,controls,163,,117.0,46.0,36.9,,,,,yes,9057100.0
patients,schizophrenia,151,schizophrenia,114.0,37.0,37.8,,,,,yes,9057100.0
healthy,awake,16,,12.0,4.0,29.0,18-40,18.0,40.0,,yes,6787094.0
healthy,anaesthetized,16,,12.0,4.0,29.0,18-40,18.0,40.0,,yes,6787094.0
patients,disorders of consciousness,22,Unresponsive Wakefulness Syndrome/Vegetative State or Minimally Conscious State,14.0,8.0,,17-70,17.0,70.0,,yes,6787094.0
patients,JME patients,18,Juvenile myoclonic epilepsy,3.0,15.0,30.1,20-48,20.0,48.0,,yes,6412974.0
healthy,healthy controls,25,,14.0,10.0,33.2,,,,,yes,6412974.0
patients,AVH,50,drug-naive first-episode schizophrenia with auditory verbal hallucinations,,,,,,,,yes,9435010.0
patients,NAVH,50,drug-naive first-episode schizophrenia without auditory verbal hallucinations,,,,,,,,yes,9435010.0
healthy,controls,50,,,,,,,,,yes,9435010.0
patients,DLB,17,Dementia with Lewy bodies,13.0,4.0,71.88,60-82,60.0,82.0,,yes,6902076.0
healthy,HC,20,,9.0,11.0,67.8,56-77,56.0,77.0,,yes,6902076.0
patients,MSA-c type,24,multiple system atrophy cerebellar type,,,,,,,,yes,7485713.0
healthy,controls,20,,,,,,,,,yes,7485713.0
healthy,controls,35,,,,,,,,,yes,5292583.0
patients,schizophrenia,34,schizophrenia,,,,,,,,yes,5292583.0
healthy,controls,163,,117.0,46.0,36.9,,,,,yes,6611425.0
patients,schizophrenia,151,schizophrenia,114.0,37.0,37.8,,,,,yes,6611425.0
patients,heroin relapsers,21,heroin addiction,21.0,0.0,35.6,null,,,,yes,4990879.0
patients,heroin non-relapsers,19,heroin addiction,19.0,0.0,39.3,null,,,,yes,4990879.0
patients,"drug-naive, first-episode schizophrenia",44,schizophrenia,,,,18-37,18.0,37.0,,yes,6197719.0
healthy,unaffected siblings,42,,,,,18-37,18.0,37.0,,yes,6197719.0
healthy,healthy controls,44,,,,,18-37,18.0,37.0,,yes,6197719.0
healthy,fMRI participants,102,,36.0,66.0,21.5,20-23,20.0,23.0,,yes,3775427.0
patients,fibromyalgia,20,fibromyalgia,0.0,20.0,46.4,22-70,22.0,70.0,,yes,6820536.0
healthy,controls,20,,0.0,20.0,42.1,21-70,21.0,70.0,,yes,6820536.0
healthy,participants,21,,9.0,12.0,23.04,18-35,18.0,35.0,,yes,6697392.0
healthy,volunteers,29,healthy,,,,,,,,yes,7563756.0
patients,PTSD,21,PTSD,,,,,,,,yes,5030332.0
patients,non-convicted CSOs,31,pedophilia,,,,,,,,yes,6678781.0
patients,convicted CSOs,48,pedophilia,,,,,,,,yes,6678781.0
healthy,fMRI participants,17,,5.0,12.0,24.0,18-31,18.0,31.0,,yes,5902547.0
patients,right MCA infarction patients,11,right middle cerebral artery (MCA) territory infarction,11.0,0.0,56.2,45-68,45.0,68.0,,yes,8154462.0
healthy,age-matched healthy controls,9,,9.0,0.0,53.7,40-67,40.0,67.0,,yes,8154462.0
healthy,all participants,23,,,,,,,,,yes,5324609.0
healthy,included participants,15,,7.0,8.0,23.8,,,,,yes,5324609.0
patients,nAMD,18,neovascular age-related macular degeneration,9.0,9.0,,,,,,yes,8544331.0
healthy,healthy controls,18,,9.0,9.0,,,,,,yes,8544331.0
patients,ALS patients,20,Amyotrophic Lateral Sclerosis (ALS),,,,,,,,yes,3447931.0
healthy,control group,20,,,,,,,,,yes,3447931.0
healthy,Study 1 participants,24,,0.0,24.0,24.0,20-30,20.0,30.0,,yes,3965851.0
healthy,Study 2 participants,18,,0.0,18.0,24.0,20-30,20.0,30.0,,yes,3965851.0
healthy,working with children,19,,9.0,10.0,24.08,null-null,,,,yes,7395771.0
healthy,not working with children,19,,9.0,10.0,24.08,null-null,,,,yes,7395771.0
patients,chronic dieters,69,chronic dieters,0.0,69.0,19.38,18-23,18.0,23.0,,yes,5460048.0
patients,panic disorder,17,panic disorder,2.0,15.0,,,,,,yes,6382839.0
healthy,controls,17,,4.0,13.0,,,,,,yes,6382839.0
patients,schizophrenia patients,44,"drug-naive, first-episode schizophrenia",,,,18-37,18.0,37.0,,yes,6197719.0
healthy,unaffected siblings,42,,,,,18-37,18.0,37.0,,yes,6197719.0
healthy,healthy controls,44,,,,,18-37,18.0,37.0,,yes,6197719.0
healthy,all participants,30,,15.0,15.0,,18-30,18.0,30.0,,yes,2748718.0
healthy,Christians,15,,7.0,8.0,,,,,,yes,2748718.0
healthy,Nonbelievers,15,,7.0,8.0,,,,,,yes,2748718.0
healthy,participants,23,,18.0,5.0,22.0,,,,,yes,4330553.0
patients,pED,26,psychogenic erectile dysfunction,26.0,0.0,26.8,,,,,yes,6290711.0
healthy,NC,26,,26.0,0.0,28.5,,,,,yes,6290711.0
healthy,7-repeat absent,16,,10.0,6.0,11.42,8-16,8.0,16.0,,yes,7005761.0
healthy,7-repeat present,10,,7.0,3.0,11.42,8-16,8.0,16.0,,yes,7005761.0
patients,ASD,15,Autism Spectrum Disorder,12.0,3.0,38.0,null,,,,yes,2648877.0
healthy,Control,18,,13.0,5.0,32.0,null,,,,yes,2648877.0
patients,tinnitus,12,chronic tinnitus,1.0,11.0,,21-72,21.0,72.0,,yes,6667657.0
patients,stroke patients,72,ischemic stroke,28.0,44.0,64.6,60-70,60.0,70.0,,yes,5665859.0
healthy,healthy volunteers,15,,,,,,,,,yes,5665859.0
patients,depressed patients,11,depression,5.0,6.0,61.0,null,,,,yes,4589842.0
healthy,healthy volunteers,11,,5.0,6.0,56.0,null,,,,yes,4589842.0
patients,DLB,16,dementia with Lewy bodies,,,,,,,,yes,3984441.0
healthy,controls,17,,,,,,,,,yes,3984441.0
patients,postpartum,24,postpartum,0.0,24.0,,,,,,yes,7272423.0
healthy,control,27,healthy control,0.0,27.0,,,,,,yes,7272423.0
healthy,all participants,19,,10.0,9.0,22.8,19-31,19.0,31.0,,yes,3869649.0
healthy,all participants,10,healthy,7.0,3.0,27.72,null,,,,yes,4029023.0
healthy,female,149,healthy,0.0,149.0,24.5,18-68,18.0,68.0,,yes,4115625.0
healthy,male,123,healthy,123.0,0.0,24.4,18-61,18.0,61.0,,yes,4115625.0
healthy,participants,18,,9.0,9.0,,20-32,20.0,32.0,,yes,4318429.0
patients,LMTLE,12,Left mesial temporal lobe epilepsy,3.0,9.0,,,,,,yes,4017227.0
patients,RMTLE,11,Right mesial temporal lobe epilepsy,5.0,6.0,,,,,,yes,4017227.0
healthy,controls,19,,10.0,9.0,,,,,,yes,4017227.0
healthy,adolescents,67,,36.0,31.0,15.6,13-18,13.0,18.0,,yes,8379626.0
healthy,all participants,58,,26.0,32.0,24.02,,,,,yes,3492343.0
healthy,control,16,,9.0,7.0,,18-35,18.0,35.0,,yes,3183226.0
healthy,adolescents,220,,115.0,105.0,14.61,14-15,14.0,15.0,,yes,3991323.0
healthy,adults,28,,17.0,11.0,25.24,20-39,20.0,39.0,,yes,3991323.0
healthy,nulliparous women,47,,0.0,47.0,19.62,,,,,yes,5548834.0
healthy,children,17,,8.0,9.0,7.4,6.9-7.8,6.0,7.0,,yes,3780305.0
healthy,participants,18,,8.0,10.0,22.5,20.7-24.3,,,,yes,6344389.0
patients,incarcerated females,157,psychopathy,0.0,157.0,,18-50,18.0,50.0,,yes,4174863.0
healthy,non-incarcerated females,46,,0.0,46.0,,18-50,18.0,50.0,,yes,4174863.0
healthy,visual task participants,6,,4.0,2.0,,,,,,yes,5596109.0
healthy,test-retest task participants,10,,4.0,6.0,52.5,50-58,50.0,58.0,52.5,yes,5596109.0
healthy,NYU resting-state participants,25,,,,,,,,,yes,5596109.0
healthy,participants,20,,10.0,10.0,22.3,19-28,19.0,28.0,,yes,7002496.0
healthy,children,20,,,,5.8,5.2-6.8,5.2,6.8,,yes,4274095.0
patients,ADHD adults,38,ADHD,18.0,20.0,40.5,18-65,18.0,65.0,,yes,6347794.0
patients,T2DM-CI,22,Type 2 diabetes mellitus with cognitive impairment,,,,45-75,45.0,75.0,,yes,7829678.0
patients,T2DM-NC,31,Type 2 diabetes mellitus with normal cognition,,,,45-75,45.0,75.0,,yes,7829678.0
healthy,HC,39,,,,,,,,,yes,7829678.0
healthy,all participants,233,,116.0,117.0,16.1,9.9-26.6,9.9,26.6,,yes,5390693.0
healthy,adolescents,51,,26.0,25.0,13.98,12.03-15.94,12.0,15.0,,yes,6664004.0
healthy,adults,51,,10.0,41.0,43.71,27.49-55.91,27.0,55.0,,no,6664004.0
healthy,adolescents_behavioral,53,,26.0,27.0,13.37,12.18-14.82,12.0,14.0,,no,6664004.0
patients,UCP patients,8,Unilateral Cerebral Palsy,3.0,5.0,,10-30,10.0,30.0,,yes,6878729.0
healthy,older adults,34,,14.0,20.0,73.2,56-83,56.0,83.0,,yes,7779563.0
healthy,participants,22,,5.0,17.0,,23-41,23.0,41.0,,yes,3483694.0
patients,WMHs,104,White matter hyperintensities,,,,40-80,40.0,80.0,,yes,8315277.0
healthy,HCs,37,Healthy controls,,,,,,,,yes,8315277.0
patients,ASD,28,autism spectrum disorder,,,13.43,10-17,10.0,17.0,,yes,5870086.0
patients,EOD,58,early adult onset depression,,,,18-29,18.0,29.0,,yes,5598991.0
patients,LOD,62,later adult onset depression,,,,30-44,30.0,44.0,,yes,5598991.0
healthy,young HC,60,,,,,,,,,yes,5598991.0
healthy,old HC,52,,,,,,,,,yes,5598991.0
healthy,right-handed participants,12,healthy,5.0,7.0,25.8,,,,,yes,7649291.0
healthy,participants,21,,21.0,0.0,25.77,20-40,20.0,40.0,,yes,5776089.0
healthy,participants,11,,8.0,3.0,33.1,25-47,25.0,47.0,,yes,6328158.0
healthy,participants,12,,6.0,6.0,25.4,20-40,20.0,40.0,,yes,2151069.0
healthy,participants,12,,7.0,5.0,38.0,23-60,23.0,60.0,,yes,4075342.0
healthy,participants,13,,6.0,7.0,28.4,19-45,19.0,45.0,,yes,7430162.0
healthy,participants,24,,12.0,12.0,,,,,,yes,3362560.0
healthy,all,10,,5.0,5.0,29.5,23-43,23.0,43.0,,yes,3407245.0
healthy,all,46,,32.0,14.0,22.61,,,,,yes,7745153.0
healthy,participants,33,,18.0,15.0,25.24,,,,,yes,7156375.0
healthy,all participants,24,,9.0,15.0,,,,,,yes,6016936.0
healthy,all,103,,52.0,51.0,32.5,18-72,18.0,72.0,,yes,3334814.0
patients,ASC,18,Autism Spectrum Condition,,,30.4,,,,,yes,4265725.0
healthy,Controls,18,,,,28.6,,,,,yes,4265725.0
patients,obese women,16,obesity,0.0,16.0,46.31,,,,,yes,5537800.0
patients,verum acupuncture,20,knee osteoarthritis,11.0,9.0,,43-70,43.0,70.0,,yes,4175730.0
patients,sham acupuncture,10,knee osteoarthritis,6.0,4.0,,43-70,43.0,70.0,,yes,4175730.0
patients,IA group,18,Internet Addiction,,,15.1,,,,,yes,4030253.0
healthy,control group,23,,,,15.2,,,,,yes,4030253.0
patients,phobic prone,15,phobic prone,9.0,6.0,39.2,,,,,yes,3002948.0
patients,eating disorders prone,15,eating disorders prone,10.0,5.0,34.4,,,,,yes,3002948.0
patients,PTSD,21,PTSD,6.0,15.0,21.5,18-31,18.0,31.0,,yes,6024199.0
healthy,trauma-exposed controls,21,,7.0,14.0,22.1,18-37,18.0,37.0,,yes,6024199.0
healthy,APOE 2/3,20,healthy,,,,18-23,18.0,23.0,,yes,3520927.0
healthy,APOE 3/4,20,healthy,,,,18-23,18.0,23.0,,yes,3520927.0
healthy,fMRI participants,20,,8.0,12.0,25.1,19-30,19.0,30.0,,yes,5218407.0
healthy,all,19,,5.0,14.0,22.6,18-27,18.0,27.0,,yes,3660406.0
healthy,all,15,,5.0,10.0,61.1,51-71,51.0,71.0,,yes,3660406.0
healthy,figure skating experts,6,,1.0,5.0,21.2,18-24,18.0,24.0,,yes,3660406.0
healthy,figure skating experts,4,,1.0,3.0,56.0,51-64,51.0,64.0,,yes,3660406.0
patients,PD patients,21,Parkinson's disease,13.0,8.0,60.8,44-73,44.0,73.0,,yes,3182403.0
healthy,football fans,56,,54.0,2.0,34.4,21-60,21.0,60.0,,yes,5460049.0
healthy,participants,31,,10.0,21.0,24.3,20-29,20.0,29.0,,yes,6847157.0
patients,stroke,10,chronic post-stroke hemiparesis,6.0,4.0,66.7,null-null,,,,yes,6585311.0
healthy,age-matched controls,9,,4.0,5.0,64.2,null-null,,,,yes,6585311.0
healthy,young adults,12,,8.0,4.0,25.2,null-null,,,,yes,6585311.0
patients,first episode psychosis,31,schizophrenia or schizoaffective disorder,26.0,5.0,26.64,,,,,yes,8550949.0
healthy,controls,35,,26.0,9.0,27.12,,,,,yes,8550949.0
healthy,fMRI participants,29,,16.0,13.0,23.6,21-33,21.0,33.0,,yes,7989009.0
healthy,participants,18,,11.0,7.0,26.7,18-60,18.0,60.0,22.5,yes,2775905.0
patients,BDD,21,Bipolar Disorder in Depressive Episode,,,,16-48,16.0,48.0,,yes,6246657.0
patients,MDD,40,Major Depressive Disorder,,,,16-48,16.0,48.0,,yes,6246657.0
healthy,HC,70,,,,,16-48,16.0,48.0,,yes,6246657.0
healthy,fMRI subjects,24,,12.0,12.0,26.0,23-34,23.0,34.0,,yes,3502502.0
healthy,DWI validation subjects,46,,21.0,25.0,30.0,19-63,19.0,63.0,,yes,3502502.0
patients,MdDS,20,Mal de Debarquement Syndrome,5.0,15.0,43.4,27-66,27.0,66.0,,yes,3510214.0
healthy,Controls,20,,5.0,15.0,43.0,23-59,23.0,59.0,,yes,3510214.0
healthy,subjects,12,,,,,,,,,yes,2995581.0
healthy,subjects,18,,,,,,,,,yes,2995581.0
healthy,right-handers,142,,71.0,71.0,26.8,20-32.7,20.0,32.0,,yes,4319399.0
healthy,left-handers,142,,73.0,69.0,24.4,18.4-30.4,18.0,30.0,,yes,4319399.0
healthy,participants,15,,15.0,0.0,22.33,,,,,yes,4838249.0
healthy,participants,28,,15.0,13.0,26.39,,,,,yes,7481390.0
healthy,older adults,40,,24.0,16.0,68.4,null,,,,yes,5717028.0
patients,MDD patients,19,MDD,,,,18-55,18.0,55.0,,yes,7875881.0
healthy,healthy controls,17,,,,,18-55,18.0,55.0,,yes,7875881.0
healthy,participants,29,,15.0,14.0,34.5,,,,,yes,6868994.0
patients,smokers,18,nicotine addiction,18.0,0.0,25.11,21-33,21.0,33.0,,yes,3409150.0
healthy,all,18,,,,,,,,,yes,4352055.0
healthy,behavioral experiment participants,23,,4.0,19.0,27.69,,,,,no,2144768.0
healthy,fMRI experiment participants,18,,9.0,9.0,23.67,19-35,19.0,35.0,,yes,2144768.0
healthy,volunteers,33,healthy,17.0,16.0,25.3,,,,,yes,3676955.0
patients,AOS,15,Apraxia of Speech,15.0,0.0,61.0,51-73,51.0,73.0,,yes,4473263.0
patients,AOS-absent,17,Stroke without Apraxia of Speech,12.0,5.0,64.0,55-73,55.0,73.0,,yes,4473263.0
healthy,controls,18,,8.0,10.0,63.0,54-72,54.0,72.0,,yes,4473263.0
patients,smokers,45,healthy smokers,37.0,8.0,27.9,null,,,,yes,3511796.0
healthy,non-smokers,44,healthy non-smokers,36.0,8.0,26.3,null,,,,yes,3511796.0
healthy,young adults,29,,10.0,19.0,23.8,19-30,19.0,30.0,,yes,8318202.0
healthy,older adults,32,,15.0,17.0,71.0,65-81,65.0,81.0,,yes,8318202.0
healthy,participants,10,,4.0,6.0,20.8,,,,,yes,6528067.0
healthy,adults,20,,12.0,8.0,24.4,19-35,19.0,35.0,,yes,3147157.0
patients,experienced HA users,13,"bilateral, sloping, sensorineural hearing loss",,,,60-80,60.0,80.0,,yes,6509414.0
patients,inexperienced HA users,14,"bilateral, sloping, sensorineural hearing loss",,,,60-80,60.0,80.0,,yes,6509414.0
healthy,right-handers,19,,7.0,12.0,24.7,19-30,19.0,30.0,,yes,2561002.0
healthy,left-handers,15,,5.0,10.0,26.1,21-35,21.0,35.0,,yes,2561002.0
healthy,ASL learners,20,,1.0,19.0,21.4,18-31,18.0,31.0,,yes,6136263.0
patients,ASD,16,Autism Spectrum Disorder,16.0,0.0,,8-18,8.0,18.0,,yes,5279905.0
healthy,TD,16,,,,,,,,,yes,5279905.0
patients,PTSD,14,PTSD,,,,,,,,yes,8785646.0
healthy,Controls,15,,,,,,,,,yes,8785646.0
healthy,all participants,56,healthy,0.0,56.0,24.3,,,,,yes,5068584.0
healthy,GnRHa group,30,healthy,0.0,30.0,,,,,,yes,5068584.0
healthy,placebo group,26,healthy,0.0,26.0,,,,,,yes,5068584.0
patients,stroke patients,27,left hemisphere stroke,17.0,10.0,59.1,48.3-69.9,,,,yes,5903407.0
healthy,controls,24,,5.0,19.0,57.0,46-68,,,,yes,5903407.0
patients,proficient deaf readers,11,deaf,3.0,8.0,28.73,19-46,19.0,46.0,,yes,3554651.0
patients,less-proficient deaf readers,10,deaf,3.0,7.0,30.0,19-45,19.0,45.0,,yes,3554651.0
patients,phantom limb pain patients,13,phantom limb pain,11.0,2.0,52.92,32-75,32.0,75.0,,yes,2494616.0
healthy,healthy volunteers,6,,,,43.0,30-56,30.0,56.0,,yes,2494616.0
patients,marijuana users,10,marijuana abuse,8.0,2.0,,,,,,yes,3742334.0
healthy,non-users,18,,11.0,7.0,,,,,,yes,3742334.0
healthy,fMRI participants,30,,9.0,21.0,23.0,,,,,yes,8018944.0
healthy,TMS participants,9,,2.0,7.0,24.0,,,,,yes,8018944.0
healthy,healthy controls,40,healthy controls,8.0,32.0,,25-63,25.0,63.0,,yes,8172304.0
patients,CSU patients,32,chronic spontaneous urticaria,6.0,26.0,,25-65,25.0,65.0,,yes,8172304.0
patients,TS children,17,Tourette syndrome,,,,,,,,yes,3877773.0
healthy,healthy control children,15,,,,,,,,,yes,3877773.0
healthy,participants,13,,8.0,5.0,21.0,20-22,20.0,22.0,,yes,6989437.0
patients,PD/AG,121,panic disorder with agoraphobia,,,,,,,,yes,6854061.0
healthy,HC,77,,,,,,,,,yes,6854061.0
patients,ADHD,30,ADHD,30.0,0.0,,10-17,10.0,17.0,,yes,4190683.0
healthy,control,30,,30.0,0.0,,10-17,10.0,17.0,,yes,4190683.0
patients,ASD,26,Autism Spectrum Disorder,,,,8-18,8.0,18.0,,yes,7194032.0
healthy,TD,28,Typically Developing,,,,8-18,8.0,18.0,,yes,7194032.0
patients,aMCI/mAD,17,amnestic mild cognitive impairment (aMCI) or mild Alzheimer's dementia (mAD),8.0,9.0,73.5,65-81,65.0,81.0,,yes,7838677.0
healthy,controls,28,,14.0,14.0,,55-81,55.0,81.0,,yes,7838677.0
patients,all,70,bipolar disorder,,,37.0,18-65,18.0,65.0,,yes,6908505.0
patients,ValVal,43,bipolar disorder,,,,,,,,yes,6908505.0
patients,Met carriers,26,bipolar disorder,,,,,,,,yes,6908505.0
patients,asthmatic patients,42,bronchial asthma,,,,,18.0,,,yes,5394595.0
healthy,healthy controls,60,,,,,,,,,yes,5394595.0
patients,GCBT group,17,bronchial asthma,7.0,10.0,50.76,,,,,yes,5394595.0
patients,total sleep deprivation group,39,healthy,22.0,17.0,33.5,21-50,21.0,50.0,,yes,7260173.0
healthy,control group,15,healthy,7.0,8.0,34.5,,,,,yes,7260173.0
patients,alcohol-dependent patients,34,alcohol dependence,34.0,0.0,,,,,,yes,5413198.0
healthy,healthy controls,26,,26.0,0.0,,,,,,yes,5413198.0
healthy,participants,20,,9.0,11.0,21.95,18-35,18.0,35.0,,yes,4810172.0
healthy,all participants,15,,8.0,7.0,,,,,,yes,2390848.0
patients,UC patients,41,mildly to moderately active ulcerative colitis,25.0,16.0,37.1,20-54,20.0,54.0,,yes,6457314.0
healthy,Healthy controls,42,,25.0,17.0,36.86,22-55,22.0,55.0,,yes,6457314.0
healthy,students,40,,21.0,19.0,21.28,18-24,18.0,24.0,,yes,8152834.0
healthy,participants,17,,17.0,0.0,23.8,20-30,20.0,30.0,,yes,3866656.0
patients,PD patients,37,Parkinson's disease,17.0,20.0,,,,,,yes,4184784.0
healthy,healthy controls,34,,22.0,12.0,,,,,,yes,4184784.0
patients,FD-PDS with comorbid MDD,24,Functional Dyspepsia - Postprandial Distress Syndrome with comorbid Major Depressive Disorder,0.0,24.0,,,,,,yes,7518235.0
patients,FD-PDS without MDD,24,Functional Dyspepsia - Postprandial Distress Syndrome without Major Depressive Disorder,0.0,24.0,,,,,,yes,7518235.0
healthy,Healthy Controls,24,,0.0,24.0,,,,,,yes,7518235.0
patients,TS patients,5,Tourette syndrome,3.0,2.0,27.0,,,,,yes,5857897.0
healthy,full sample,113,,,,17.11,12.27-21.96,12.0,21.0,,yes,7038454.0
healthy,neuroimaging sample,104,,,,,,,,,yes,7038454.0
healthy,all participants,50,healthy,,,,,,,,yes,3893192.0
healthy,happy group,25,healthy,,,,,,,,yes,3893192.0
healthy,unhappy group,25,healthy,,,,,,,,yes,3893192.0
patients,MDD patients,29,"first-episode, drug-naive major depressive disorder",9.0,21.0,,18-45,18.0,45.0,,yes,4869560.0
healthy,healthy subjects,29,,15.0,14.0,26.76,,,,,yes,4869560.0
healthy,all participants,24,,12.0,12.0,25.3,21-34,21.0,34.0,,yes,7994216.0
patients,IMP,10,idiopathic musculoskeletal pain,1.0,9.0,16.3,14-17,14.0,17.0,,yes,5686883.0
healthy,control,10,,1.0,9.0,16.1,,,,,yes,5686883.0
healthy,male participants,12,healthy,12.0,0.0,31.0,18-55,18.0,55.0,,yes,3258233.0
healthy,all participants,595,,218.0,377.0,39.47,8-83,8.0,83.0,,yes,8615904.0
healthy,experiment 1,12,,6.0,6.0,26.0,23-39,23.0,39.0,,yes,3422286.0
healthy,experiment 2,14,,7.0,7.0,23.0,24-30,24.0,30.0,,yes,3422286.0
patients,mTBI,53,mild traumatic brain injury,,,,,18.0,,,yes,7275020.0
healthy,controls,37,,,,,,,,,yes,7275020.0
healthy,all participants,23,,11.0,12.0,24.2,18-31,18.0,31.0,,yes,4436102.0
healthy,Back-Pain control group,8,chronic lumbar back-pain,,,,,,,,no,4522562.0
patients,Epilepsy control group,10,epilepsy,,,,,,,,no,4522562.0
patients,Brain-operated group,14,refractory epilepsy,,,,,,,,no,4522562.0
healthy,fMRI participants,8,,4.0,4.0,31.75,,,,,yes,4522562.0
patients,mild to moderate depression,12,Major Depressive Disorder,,,,,,,,yes,4983635.0
patients,severe depression,18,Major Depressive Disorder,,,,,,,,yes,4983635.0
patients,very severe depression,15,Major Depressive Disorder,,,,,,,,yes,4983635.0
patients,all MDD patients,45,Major Depressive Disorder,16.0,29.0,37.0,19-58,19.0,58.0,,yes,4983635.0
healthy,controls,19,,8.0,11.0,33.0,20-52,20.0,52.0,,yes,4983635.0
patients,PD,42,Parkinson's disease,,,,,45.0,,,yes,6389716.0
healthy,NC,40,Normal controls,,,,,,,,yes,6389716.0
healthy,adolescents,55,,17.0,38.0,13.0,12-14,12.0,14.0,,yes,7057279.0
healthy,designers,24,,10.0,14.0,34.5,,,,,yes,8699602.0
healthy,participants,55,,55.0,0.0,24.255,18-35,18.0,35.0,,yes,6434022.0
healthy,implementation intention,20,,10.0,10.0,20.0,18-23,18.0,23.0,,yes,4370584.0
healthy,goal intention,20,,10.0,10.0,20.0,18-23,18.0,23.0,,yes,4370584.0
healthy,participants,14,,6.0,8.0,24.8,22-29,22.0,29.0,,yes,3078751.0
healthy,men,36,,36.0,0.0,37.0,22-55,22.0,55.0,,yes,7913329.0
healthy,women,27,,0.0,27.0,37.0,22-55,22.0,55.0,,yes,7913329.0
patients,anorexia nervosa,24,anorexia nervosa,0.0,24.0,,,,,,yes,4530666.0
healthy,control,25,,0.0,25.0,,,,,,yes,4530666.0
healthy,participants,31,,16.0,15.0,,18-22,18.0,22.0,,yes,3539852.0
healthy,delay conditioning group,13,,5.0,8.0,23.1,null-null,,,,yes,4034409.0
healthy,trace conditioning group,13,,4.0,9.0,23.5,null-null,,,,yes,4034409.0
healthy,male subjects,7,,7.0,0.0,23.5,21-28,21.0,28.0,,yes,7406917.0
patients,SAD,27,social anxiety disorder,15.0,12.0,,,,,,yes,4029608.0
healthy,HC,27,,14.0,13.0,,,,,,yes,4029608.0
healthy,Experiment 1,18,,10.0,8.0,26.3,21-41,21.0,41.0,,yes,3869681.0
healthy,Experiment 2,18,,9.0,9.0,26.6,21-38,21.0,38.0,,yes,3869681.0
healthy,participants,20,,20.0,0.0,23.9,18-33,18.0,33.0,,yes,4255751.0
patients,ET patients,21,Essential Tremor,12.0,9.0,51.6,null,,,,yes,4732188.0
healthy,Healthy controls,21,,14.0,7.0,50.6,null,,,,yes,4732188.0
patients,deaf CS users,14,congenital deafness,3.0,11.0,25.0,18-33,18.0,33.0,,yes,5371603.0
healthy,normally hearing,15,,6.0,9.0,25.17,20-37,20.0,37.0,,yes,5371603.0
healthy,musicians,9,,6.0,3.0,23.0,19-27,19.0,27.0,,yes,5719057.0
patients,MS patients,44,relapsing-remitting multiple sclerosis,,,,18-55,18.0,55.0,,yes,6200185.0
healthy,healthy controls,25,,,,,,,,,yes,6200185.0
healthy,volunteers,18,,,,,18-36,18.0,36.0,,yes,4280551.0
healthy,all participants,20,,12.0,8.0,24.0,null-null,,,,yes,4477935.0
patients,HFS patients,30,hemifacial spasm,12.0,18.0,48.87,,,,,yes,8569140.0
healthy,Healthy controls,30,,12.0,18.0,47.63,,,,,yes,8569140.0
patients,essential tremor,10,essential tremor,6.0,4.0,69.4,60.5-78.3,60.0,78.0,,yes,7493988.0
healthy,controls,10,,5.0,5.0,67.7,59.9-75.5,59.0,75.0,,yes,7493988.0
healthy,all participants,48,healthy,24.0,24.0,26.4,,,,,yes,2993660.0
healthy,participants,17,,0.0,17.0,20.7,18-23,18.0,23.0,,yes,6688454.0
healthy,participants,10,,7.0,3.0,26.6,,,,,yes,8893203.0
healthy,participants,18,,9.0,9.0,30.3,null-null,,,,yes,6726765.0
patients,SCD,35,subjective cognitive decline (SCD),,,,55-75,55.0,75.0,,yes,7090024.0
healthy,healthy controls,32,healthy,,,,,,,,yes,7090024.0
healthy,participants,11,,7.0,4.0,28.0,,,,,yes,6198067.0
healthy,participants,16,,8.0,8.0,25.6,22-30,22.0,30.0,,yes,3889700.0
healthy,participants,20,,9.0,11.0,23.0,18-27,18.0,27.0,,yes,7339141.0
patients,glioma patients,5,supratentorial glioma,2.0,3.0,33.7,,,,,yes,6699415.0
patients,SAD,53,Social Anxiety Disorder,36.0,17.0,29.9,,,,,yes,4416052.0
healthy,Control,33,,19.0,14.0,29.4,,,,,yes,4416052.0
healthy,all participants,25,,0.0,25.0,21.04,,,,,yes,4975394.0
healthy,included in imaging analysis,18,,0.0,18.0,21.04,,,,,yes,4975394.0
healthy,HCD group,7,healthy,2.0,5.0,31.0,,,,,yes,7758977.0
healthy,fasting group,6,healthy,1.0,5.0,29.0,,,,,yes,7758977.0
patients,IPD patients,50,Idiopathic Parkinson's disease (IPD),29.0,21.0,57.7,,,,,yes,6675526.0
healthy,healthy controls,20,,11.0,9.0,54.6,,,,,yes,6675526.0
healthy,participants,19,,12.0,7.0,27.9,,,,,yes,7456884.0
patients,VaMCI,31,vascular mild cognitive impairment (VaMCI),,,,,,,,yes,6350268.0
healthy,NC,32,normal controls (NCs),,,,,,,,yes,6350268.0
healthy,participants,33,,33.0,0.0,23.86,19-32,19.0,32.0,,yes,4380440.0
patients,PD-A,18,Parkinson's disease with anxiety,,,,,,,,yes,5655292.0
patients,PD-NA,45,Parkinson's disease without anxiety,,,,,,,,yes,5655292.0
healthy,Healthy Controls,24,,,,,,,,,yes,5655292.0
patients,childhood abuse,21,history of childhood physical abuse,15.0,6.0,17.5,,,,,yes,5104469.0
patients,psychiatric controls,19,matched psychiatric conditions,9.0,10.0,16.9,,,,,yes,5104469.0
healthy,healthy controls,27,no history of psychiatric illness or childhood maltreatment,21.0,6.0,17.5,,,,,yes,5104469.0
healthy,typically developing children,57,,31.0,26.0,10.19,,,,,yes,7099000.0
healthy,study participants,15,,15.0,0.0,26.0,,,,,yes,5270359.0
healthy,Experiment 1,15,,,,26.0,,,,,yes,4458841.0
healthy,Experiment 2,14,,,,28.0,,,,,yes,4458841.0
healthy,younger adults,28,,19.0,9.0,24.39,18-34,18.0,34.0,,yes,7004957.0
healthy,older adults,24,,15.0,9.0,66.95,55-75,55.0,75.0,,yes,7004957.0
healthy,all subjects,40,,32.0,8.0,20.5,18-28,18.0,28.0,,yes,3605341.0
patients,developmental dyscalculia,17,developmental dyscalculia,,,,8-11,8.0,11.0,,yes,5758587.0
healthy,typically developing,11,,,,,8-11,8.0,11.0,,yes,5758587.0
patients,phobic,12,cockroach phobia,4.0,8.0,40.08,null,,,,yes,6220927.0
healthy,non-phobic,12,,4.0,8.0,24.08,null,,,,yes,6220927.0
healthy,control,19,,12.0,7.0,,,,,,yes,3045463.0
patients,Parkinson's disease,21,Parkinson's disease,14.0,7.0,,,,,,yes,3045463.0
patients,chronic pain,13,chronic muscle-skeletal low back pain,4.0,9.0,51.8,43-65,43.0,65.0,52.0,yes,4048172.0
healthy,normal controls,13,,4.0,9.0,48.7,38-62,38.0,62.0,46.0,yes,4048172.0
healthy,CantoneseMandarinEnglish trilinguals,30,,10.0,20.0,,18-25,18.0,25.0,,yes,5881103.0
healthy,participants,20,,16.0,4.0,28.0,20-36,20.0,36.0,,yes,4717328.0
healthy,young adults,6,healthy,5.0,1.0,,22-35,22.0,35.0,,yes,3894920.0
patients,mood and anxiety disorder,223,mood and/or anxiety disorder,61.0,162.0,36.0,25-47,25.0,47.0,,yes,7082218.0
healthy,healthy control,45,,22.0,23.0,32.0,21-43,21.0,43.0,,yes,7082218.0
patients,A1 carriers,24,DRD2 TaqIA A1 allele carriers,,,23.65,18-30,18.0,30.0,,yes,3672681.0
healthy,A2 homozygotes,22,DRD2 TaqIA A2 homozygotes,,,23.65,18-30,18.0,30.0,,yes,3672681.0
healthy,all participants,32,,17.0,15.0,26.0,25-27,25.0,27.0,,yes,4332461.0
healthy,low BrAC group,16,,,,,,,,,yes,4332461.0
healthy,high BrAC group,16,,,,,,,,,yes,4332461.0
patients,male cocaine users,27,cocaine use disorder,27.0,0.0,,,18.0,45.0,,yes,8459240.0
patients,female cocaine users,28,cocaine use disorder,0.0,28.0,,,18.0,45.0,,yes,8459240.0
healthy,male non-cocaine users,26,,26.0,0.0,,,18.0,45.0,,yes,8459240.0
healthy,female non-cocaine users,28,,0.0,28.0,,,18.0,45.0,,yes,8459240.0
healthy,volunteers,10,healthy,3.0,7.0,39.8,18-50,18.0,50.0,,yes,2935390.0
patients,binge drinkers,12,binge drinkers,7.0,5.0,23.8,19-32,19.0,32.0,,yes,3791281.0
healthy,controls,12,healthy controls,7.0,5.0,23.8,19-32,19.0,32.0,,yes,3791281.0
healthy,participants,27,,,,24.9,20-38,20.0,38.0,,yes,6646524.0
patients,heroin relapsers,21,heroin addiction,21.0,0.0,,,,,,yes,4990879.0
patients,heroin non-relapsers,19,heroin addiction,19.0,0.0,,,,,,yes,4990879.0
patients,aphasia,39,chronic left hemisphere stroke with history of aphasia,,,,,,,,yes,5266856.0
healthy,control,37,,,,,,,,,yes,5266856.0
patients,ASD,42,Autism Spectrum Disorder,,,,8-36,8.0,36.0,,yes,3842522.0
healthy,TD,48,Typically Developing,,,,8-36,8.0,36.0,,yes,3842522.0
patients,MTLE patients,19,mesial temporal lobe epilepsy,11.0,8.0,45.3,null-null,,,,yes,7836234.0
healthy,healthy controls,19,,10.0,9.0,45.8,null-null,,,,yes,7836234.0
healthy,Control,22,,16.0,6.0,16.0,12-20,12.0,20.0,,yes,3701149.0
patients,AH,12,subclinical auditory hallucinations,5.0,7.0,15.97,12-20,12.0,20.0,,yes,3701149.0
patients,22q11.2DS,13,22q11.2 deletion syndrome,9.0,4.0,16.14,12-20,12.0,20.0,,yes,3701149.0
healthy,all participants,12,,6.0,6.0,,22-48,22.0,48.0,,yes,3788350.0
patients,AN,31,anorexia nervosa,0.0,31.0,,,,,,yes,3913832.0
healthy,HC,31,,0.0,31.0,,,,,,yes,3913832.0
healthy,participants,20,,14.0,6.0,24.0,20-34,20.0,34.0,,yes,8764488.0
healthy,all participants,11,healthy normal,5.0,6.0,31.0,25-38,25.0,38.0,,yes,3132672.0
healthy,fMRI participants,16,,6.0,10.0,23.1,19-29,19.0,29.0,,yes,5832413.0
healthy,participants,16,,10.0,6.0,30.1,18-40,18.0,40.0,,yes,4072722.0
patients,former iron deficient anemic,14,former iron deficiency anemia in infancy,8.0,6.0,21.5,null,,,,yes,5339238.0
healthy,controls,17,healthy controls,9.0,8.0,21.5,null,,,,yes,5339238.0
healthy,entire sample,31,,,,26.0,25-27,25.0,27.0,,yes,5890144.0
patients,multi-problem young adults,100,multi-problem young adults,100.0,0.0,,18-27,18.0,27.0,,yes,6004505.0
healthy,healthy controls,22,,22.0,0.0,,,,,,yes,6004505.0
patients,ADHD,19,ADHD,,,,,,,,yes,4936600.0
patients,DCD,6,DCD,,,,,,,,yes,4936600.0
patients,DCD+ADHD,14,DCD and ADHD,,,,,,,,yes,4936600.0
healthy,Typically developing,21,,,,,,,,,yes,4936600.0
healthy,all participants,15,,5.0,10.0,31.6,22-54,22.0,54.0,,yes,7981326.0
healthy,participants,18,,10.0,8.0,25.0,22-29,22.0,29.0,,yes,4493392.0
healthy,proposers,45,,18.0,27.0,24.49,,,,,yes,5428836.0
patients,very preterm birth,24,very preterm birth (<33 weeks of gestation),,,,,,,,yes,4215530.0
healthy,controls,22,full-term birth,,,,,,,,yes,4215530.0
patients,patients,17,schizophrenia or schizoaffective disorder,,,,,,,,yes,7851842.0
healthy,controls,18,healthy,,,,,,,,yes,7851842.0
healthy,participants,33,,17.0,16.0,26.0,20-48,20.0,48.0,,yes,5447679.0
patients,mTBI,50,mild traumatic brain injury,25.0,25.0,,20-58,20.0,58.0,,yes,7539836.0
healthy,controls,43,,19.0,24.0,,20-59,20.0,59.0,,yes,7539836.0
healthy,participants,34,,19.0,15.0,,18-25,18.0,25.0,,yes,6908964.0
healthy,behavioral experiment participants,22,,17.0,5.0,,19-41,19.0,41.0,,no,4349631.0
healthy,fMRI experiment participants,16,,11.0,5.0,,20-59,20.0,59.0,,yes,4349631.0
patients,OCD patients,19,obsessive-compulsive disorder,,,,,,,,yes,3777673.0
healthy,control participants,19,,,,,,,,,yes,3777673.0
healthy,all participants,15,,8.0,7.0,22.21,null-null,,,,yes,6195265.0
healthy,men,12,,12.0,0.0,,23-45,23.0,45.0,,yes,2525845.0
healthy,women_early_follicular,12,,0.0,12.0,,23-45,23.0,45.0,,yes,2525845.0
healthy,women_midluteal,12,,0.0,12.0,,23-45,23.0,45.0,,yes,2525845.0
healthy,fMRI participants,22,,11.0,11.0,23.3,,,,,yes,6215330.0
healthy,EEG participants,21,,9.0,12.0,26.76,,,,,yes,6215330.0
healthy,fMRI participants,15,,8.0,7.0,26.5,21-38,21.0,38.0,,yes,3324921.0
patients,epilepsy patients,5,epilepsy,2.0,3.0,25.0,,,,,yes,3324921.0
patients,asymptomatic carotid artery stenosis,16,asymptomatic carotid artery stenosis,,,,55-80,55.0,80.0,,yes,5552726.0
patients,AD,14,Alzheimer's disease (AD),,,,,,,,yes,3423412.0
patients,MCI,8,Mild Cognitive Impairment (MCI),,,,,,,,yes,3423412.0
healthy,control,14,,,,,,,,,yes,3423412.0
patients,NDPH,29,new daily persistent headache,15.0,14.0,37.0,null,,,,yes,10958407.0
healthy,controls,37,,16.0,21.0,34.89,null,,,,yes,10958407.0
patients,MS patients,122,relapsing-remitting multiple sclerosis,38.0,84.0,37.6,null,,,,yes,11033924.0
healthy,healthy controls,97,,41.0,56.0,38.1,null,,,,yes,11033924.0
healthy,all,229,neurotypical,114.0,115.0,21.58,17-29,17.0,29.0,,yes,10980722.0
healthy,all participants,73,,29.0,44.0,22.3,18-39,18.0,39.0,,no,10956805.0
patients,AD patients,16,Alzheimer's disease,,,,,,,,yes,11024046.0
healthy,healthy controls,16,,,,,,,,,yes,11024046.0
healthy,all_participants,50,,11.0,39.0,21.6,,,,,yes,11063816.0
patients,all_patients,48,focal epilepsy,15.0,33.0,,,,,28.0,yes,10839335.0
healthy,all participants,13,,12.0,1.0,24.0,19-29,19.0,29.0,,yes,10839845.0
healthy,healthy controls,55,healthy controls,,,,,,,,yes,10850607.0
patients,BPPV with RD,55,BPPV with residual dizziness,,,,,,,,yes,10850607.0
patients,BPPV without RD,55,BPPV without residual dizziness,,,,,,,,yes,10850607.0
patients,all_patients,28,refractory epilepsy,,,,16-60,16.0,60.0,,yes,11069337.0
patients,temporal_lobe_epilepsy,20,temporal lobe epilepsy,,,,,,,,yes,11069337.0
patients,extratemporal_lobe_epilepsy,8,extratemporal lobe epilepsy,,,,,,,,yes,11069337.0
patients,normal cognition,27,Parkinson's disease with normal cognition,,,,,,,,yes,10999557.0
patients,mild cognitive impairment,21,Parkinson's disease with mild cognitive impairment,18.0,3.0,,,,,,yes,10999557.0
patients,severe cognitive impairment,10,Parkinson's disease with severe cognitive impairment,,,74.4,,,,,yes,10999557.0
healthy,all,395,,,,,22-36,22.0,36.0,,yes,11000510.0
patients,fMRI-LITT candidates,7,intracranial lesions in or near eloquent structures,,,,,,,,yes,10844152.0
patients,CSM patients,78,cervical spondylotic myelopathy,,,,20-75,20.0,75.0,,yes,10877862.0
patients,BPD patients,30,borderline personality disorder,1.0,29.0,24.22,null,,,,yes,10870473.0
healthy,Healthy controls,30,null,1.0,29.0,24.66,null,,,,yes,10870473.0
healthy,young adults,22,,22.0,0.0,22.8,21.6-24,22.0,24.0,,yes,10858222.0
healthy,controls,31,,,,,,18.0,65.0,,yes,10995093.0
patients,unipolar depression,27,major depressive disorder,,,,,18.0,65.0,,yes,10995093.0
patients,bipolar depression,21,bipolar disorder,,,,,18.0,65.0,,yes,10995093.0
patients,CUD patients,54,Cocaine use disorder,46.0,8.0,,,,,,yes,11035677.0
